Skip to content
10-Q

Quarterly Report

Forte Biosciences, Inc. FBRX

0001193125-25-281808

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 12.53M sh
Capex Q3 2025 · Sep 30, 2025 $116K
Capex Q3 2025 · Sep 30, 2024 $6K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$34.42M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$20.74M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $93.41M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $22.24M
Stockholders Equity Q3 2025 · Sep 30, 2025 $84.1M
Stockholders Equity Q3 2025 · Jun 30, 2025 $98.61M
Stockholders Equity Q3 2025 · Mar 31, 2025 $38.43M
Stockholders Equity Q3 2025 · Dec 31, 2024 $52.48M
Stockholders Equity Q3 2025 · Sep 30, 2024 $9.37M
Stockholders Equity Q3 2025 · Jun 30, 2024 $16.96M
Stockholders Equity Q3 2025 · Mar 31, 2024 $28.69M
Stockholders Equity Q3 2025 · Dec 31, 2023 $35.31M
Current Liabilities Q3 2025 · Sep 30, 2025 $12.99M
Current Liabilities Q3 2025 · Dec 31, 2024 $9.08M
Current Assets Q3 2025 · Sep 30, 2025 $95.41M
Current Assets Q3 2025 · Dec 31, 2024 $61.35M
Total Assets Q3 2025 · Sep 30, 2025 $97.09M
Total Assets Q3 2025 · Dec 31, 2024 $61.56M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.99
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.26
Eps Diluted Q3 2025 · Sep 30, 2024 −$4.54
Eps Diluted Q3 2025 · Sep 30, 2024 −$15.35
Eps Basic Q3 2025 · Sep 30, 2025 −$0.99
Eps Basic Q3 2025 · Sep 30, 2025 −$3.26
Eps Basic Q3 2025 · Sep 30, 2024 −$4.54
Eps Basic Q3 2025 · Sep 30, 2024 −$15.35
Sga Expense Q3 2025 · Sep 30, 2025 $3.18M
Sga Expense Q3 2025 · Sep 30, 2025 $9.58M
Sga Expense Q3 2025 · Sep 30, 2024 $2.76M
Sga Expense Q3 2025 · Sep 30, 2024 $13.29M
Net Income Q3 2025 · Sep 30, 2025 −$17.68M
Net Income Q3 2025 · Sep 30, 2025 −$44.59M
Net Income Q3 2025 · Jun 30, 2025 −$11.25M
Net Income Q3 2025 · Mar 31, 2025 −$15.66M
Net Income Q3 2025 · Sep 30, 2024 −$8.39M
Net Income Q3 2025 · Sep 30, 2024 −$28.32M
Net Income Q3 2025 · Jun 30, 2024 −$12.51M
Net Income Q3 2025 · Mar 31, 2024 −$7.42M
Operating Income Q3 2025 · Sep 30, 2025 −$18.38M
Operating Income Q3 2025 · Sep 30, 2025 −$46.09M
Operating Income Q3 2025 · Sep 30, 2024 −$8.63M
Operating Income Q3 2025 · Sep 30, 2024 −$29.25M
Short Term Investments Q3 2025 · Dec 31, 2024 $36.12M